Retroperitoneal fibrosis
Information
- Disease name
- Retroperitoneal fibrosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01584388 | Completed | Phase 1/Phase 2 | Rituximab in IgG4-RD: A Phase 1-2 Trial | April 2012 | January 2015 |
| NCT02705638 | Completed | Phase 1 | Treatment of IgG4-Related Disease With Revlimid and Rituximab | April 2016 | April 2019 |
| NCT04047576 | Recruiting | Phase 2/Phase 3 | Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis | July 1, 2018 | December 2026 |
| NCT06065852 | Recruiting | National Registry of Rare Kidney Diseases | November 6, 2009 | December 31, 2039 | |
| NCT00440349 | Unknown status | Phase 2 | Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis | October 2000 | April 2007 |
| NCT03133949 | Unknown status | Aortitis and Retroperitoneal Fibrosis: Evaluation of Diagnostic Criteria | July 8, 2010 | July 8, 2020 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0005200
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012185